Monitoring and Management for Metabolic Side Effects of Antipsychotics

Completed · Not applicable

Conditions studied: Mental Health, Psychotic Disorders

In brief

The purpose of this study is to test an approach for implementing guideline recommendations for assessing and managing metabolic side effects (including weight gain, diabetes, elevated lipids) in patients prescribed antipsychotic medications.

Key facts

Study ID

NCT01875861

Run by

VA Office of Research and Development

People needed

12

Starts

2011-01-01

Expected to finish

2017-04-01

Last updated by the study team

2019-02-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Providers involved in antipsychotic management or management of metabolic side effects and related conditions

You may not qualify if…

• None

Where it is running

• Central Arkansas Veterans Healthcare System Eugene J. Towbin Healthcare Center, Little Rock, AR — North Little Rock, Arkansas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.